Feasibility of point of care testing for prevention and management of breast cancer therapy associated comorbidities in 6 African countries: short communication

Objective: Obesity and mediators of inflammation have been identified as the most important risk and predictive factors in postmenopausal breast cancer (BC) survivors using aromatase inhibitors (AIs). This study was conducted to assess the impact of point of care technology (PCOT) as part of patholo...

Full description

Saved in:

Bibliographic Details
Published in:	BMC research notes Vol. 15; no. 1; pp. 1 - 5
Main Authors:	Milambo, Jean Paul Muambngu, Ndirangu, James, Nyasulu, Peter S, Akudugu, John M
Format:	Journal Article
Language:	English
Published:	London BioMed Central 22.10.2022 BioMed Central Ltd Springer Nature B.V BMC
Subjects:	Adverse and side effects Adverse events Aromatase Aromatase inhibitors Biomedical and Life Sciences Biomedicine Body fat Body mass index Breast cancer C-reactive protein Cancer therapies Cardiovascular risk factors Care and treatment Comorbidity Diagnosis Drugs Estrogens Ferritin Genetic screening Genetic testing Homocysteine Inflammation Laboratories Life Sciences Lifestyles Medical diagnosis Medical screening Medicine/Public Health Obesity Pathology Patients Point of care testing Post-menopause Postmenopausal breast cancer Research Note Risk factors Statistical analysis Womens health South Africa Africa Cardiovascular risk factors Point of care testing Postmenopausal breast cancer Aromatase inhibitors
ISSN:	1756-0500, 1756-0500
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!